Palisade Bio, Inc.
PALI · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | – |
| R&D Expenses | $9 | $7 | $7 | $2 |
| G&A Expenses | $6 | $6 | $9 | $9 |
| SG&A Expenses | $6 | $6 | $9 | $9 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $30 |
| Operating Expenses | $15 | $13 | $16 | $42 |
| Operating Income | -$15 | -$13 | -$16 | -$42 |
| % Margin | – | -5,228% | – | – |
| Other Income/Exp. Net | $0 | $1 | $1 | $15 |
| Pre-Tax Income | -$14 | -$12 | -$14 | -$27 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$14 | -$12 | -$14 | -$27 |
| % Margin | – | -4,920% | – | – |
| EPS | -10.19 | -27.01 | -16.53 | -2,144.25 |
| % Growth | 62.3% | -63.4% | 99.2% | – |
| EPS Diluted | -10.19 | -27.01 | -16.53 | -2,546.1 |
| Weighted Avg Shares Out | 1 | 0 | 1 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 1 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$14 | -$12 | -$14 | -$24 |
| % Margin | – | -4,912.4% | – | – |